AEON Biopharma, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
AEON NYSE American 2836 www.aeonbiopharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AEON Biopharma, Inc.

AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions - Jan 21st, 2026 2:05 pm
An Intrinsic Calculation For Aeon Co. (M) Bhd. (KLSE:AEON) Suggests It's 42% Undervalued - Jan 14th, 2026 12:37 am
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 - Dec 19th, 2025 4:00 pm
AEON Biopharma Announces Execution of Exchange Agreement with Daewoong - Dec 15th, 2025 2:05 pm
Investors in Aeon (M) Bhd (KLSE:AEON) have unfortunately lost 24% over the last year - Dec 14th, 2025 7:14 pm
AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling - Nov 20th, 2025 6:30 am
AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth - Nov 14th, 2025 6:30 am
AEON Biopharma Reports Positive and Robust Biosimilarity Results: Identical Amino Acid Sequence and Highly Similar Functional Analysis Data - Nov 13th, 2025 6:30 am
The Returns At Aeon (M) Bhd (KLSE:AEON) Aren't Growing - Oct 22nd, 2025 12:14 am
AEON Biopharma Announces FDA BPD Type 2a Meeting for ABP-450 on November 19 - Oct 1st, 2025 6:00 am
Aeon Co. (M) Bhd.'s (KLSE:AEON) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? - Sep 28th, 2025 6:02 pm
Aeon Co. (M) Bhd.'s (KLSE:AEON) largest shareholders are public companies with 52% ownership, institutions own 33% - Sep 11th, 2025 9:41 pm
Aeon (M) Bhd Second Quarter 2025 Earnings: EPS: RM0.009 (vs RM0.02 in 2Q 2024) - Aug 26th, 2025 4:11 pm
AEON Biopharma Reports Second Quarter 2025 Financial Results and Provides Corporate Update - Aug 12th, 2025 2:05 pm
Are Investors Undervaluing Aeon Co. (M) Bhd. (KLSE:AEON) By 39%? - Aug 7th, 2025 12:07 am
Those who invested in Aeon (M) Bhd (KLSE:AEON) five years ago are up 66% - Jul 7th, 2025 1:17 am
AEON Biopharma to Present at the Aegis Capital Corp. Virtual Conference 2025 - May 19th, 2025 2:05 pm
AEON Biopharma Reports First Quarter 2025 Financial Results and Provides Corporate Update - May 14th, 2025 2:05 pm
AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance - Apr 25th, 2025 2:05 pm
AEON Biopharma Appoints Industry Veteran Rob Bancroft as Chief Executive Officer - Apr 21st, 2025 2:05 pm